Nexium Dyspepsia/AST
Nexium Dyspepsia/AST
The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during
 an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms
 resolution at the end of a subsequent treatment period of 7 weeks.
Inclusion Criteria:

 -  At least 3 months of symptoms of pain or burning centered in the upper abdomen prior
 to enrollment.

 -  Both Helicobacter pylori positive and negative patients eligible (Helicobacter pylori
 is a bacterial infection of the stomach)

 Exclusion Criteria:

 -  Presence of clinical significant abnormal findings at the endoscopy (examination of
 esophagus and stomach) prior to enrollment.

 -  Patients with symptoms of other gastrointestinal diseases, such as Gastroesophageal
 Reflux Disease (GERD), Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease
 (IBD).

 -  Helicobacter pylori eradication treatment during the last 12 months prior to
 enrollment.